Pharmacotherapy for smoking.
Department of Family Medicine, University of Alberta, Edmonton.
G Michael
GM
Allan
Noah
N
Ivers
Charl
C
Els
D001552:Benzazepines / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D006801:Humans; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D009661:Nortriptyline / Q000627:therapeutic use; D011810:Quinoxalines / Q000627:therapeutic use; D012907:Smoking / Q000188:drug therapy*; D016540:Smoking Cessation / Q000379:methods*; D061485:Tobacco Use Cessation Devices; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D016642:Bupropion; D009661:Nortriptyline; D000068580:Varenicline
BMJ. 2009 Oct 01;339:b3805
19797344
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000165
18425860
N Engl J Med. 1997 Oct 23;337(17):1195-202
9337378
Clin Ther. 2007 Jun;29(6):1040-56
17692720
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002850
16855992
Arch Intern Med. 2006 Aug 14-28;166(15):1571-7
16908789
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146
18253970
Am J Public Health. 2007 Oct;97(10):1878-83
17761570
JAMA. 2006 Jul 5;296(1):56-63
16820547
Chest. 2007 Feb;131(2):446-52
17296646
Prev Med. 2010 Sep-Oct;51(3-4):199-213
20600264
Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103
18646137
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000031
17253443